We are one of the leading complex drug delivery and formulation developers, using our key in-house technologies to support improved patient compliance.

Our portfolio consists of over 100 products, and today we are working on one of the most extensive and advanced pipelines in Long Acting Injectables, Sustained Release formulations and Preservative Free Ophthalmics, produced in our in-house US-FDA and EU-approved facilities. We service a broad partner network of over 250 customers in over 90 countries throughout Europe, North America, South America, Middle East, Asia, Australasia and Southern Africa.

In Long Acting Injectables all 3 key technology platforms (Microspheres, Nanosuspensions and Nano-Gels) are fully validated to commercial scale across multiple products in multiple countries. These platforms now support the enrichment of our pipeline with our selection of Long-Acting Therapeutic Technologies (LATTs) which target enhanced patient compliance for existing drug delivery methods and support Life Cycle Management (LCM) opportunities.

At Pharmathen, we proudly employ more than 1,200 people from over 22 different nationalities across 9 locations. Based on our dynamic and extrovert culture, we remain committed to our vision “to make a difference in people’s lives” through our everyday activities and our products.